| Identification | Back Directory | [Name]
1H-1,2,3-Triazole, 1,4-bis(3,4,5-trimethoxyphenyl)- | [CAS]
876013-29-5 | [Synonyms]
TNF/IFN-γ-IN-1
1H-1,2,3-Triazole, 1,4-bis(3,4,5-trimethoxyphenyl)- | [Molecular Formula]
C20H23N3O6 | [MOL File]
876013-29-5.mol | [Molecular Weight]
401.41 |
| Chemical Properties | Back Directory | [Boiling point ]
549.4±60.0 °C(Predicted) | [density ]
1.24±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
-1.81±0.70(Predicted) | [color ]
Off-white to light brown |
| Hazard Information | Back Directory | [Uses]
TNF/IFN-γ-IN-1 (compound TGA) is a dual inhibitor of TNF and IFN-γ. TNF/IFN-γ-IN-1 can used in study Alzheimer’s disease[1]. | [References]
[1] Andrade VHB, et al. Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive Impairment. ACS Chem Neurosci. 2023 Dec 20;14(24):4298-4310. DOI:10.1021/acschemneuro.3c00443 |
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|